Trial Details
COMPLETEDBasic Information
| Clinical ID | c4617 |
|---|---|
| Identifier | NCT00258193 |
| Trial Title | Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: MD-1100 Acetate |
Participant Information
| Sponsor | Ironwood Pharmaceuticals, Inc. |
|---|---|
| City | Rochester |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2006-01 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2006-09 |